Literature DB >> 11352862

Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma.

P A Kanetsky1, R Holmes, A Walker, D Najarian, J Swoyer, D Guerry, A Halpern, T R Rebbeck.   

Abstract

The mu and theta classes of glutathione S-transferases (GST) may affect the development of cutaneous malignant melanoma (CMM) by decreasing cellular oxidative stress in skin. These isozymes are absent in a large proportion of the population because of germ-line homozygous deletions in the genes encoding GSTM1 and GSTT1. To determine the association between GSTM1 and GSTT1 homozygous deletions (GSTM1 null and GSTT1 null, respectively) and CMM, we studied 212 patients with CMM, 150 patients with CMM and dysplastic nevi (DN), 147 patients with DN alone, and 124 healthy persons without CMM or DN. Comparing CMM cases (n = 362) to participants without CMM (n = 271), we found no association with GSTM1 null [odds ratio (OR), 1.2; 95% confidence interval (CI), 0.86-1.6] or GSTT1 null (OR, 0.82; 95% CI, 0.56-1.2), either independently or in combination (OR, 1.4; 95% CI, 0.81-2.2), after adjusting for age. However, among the subset of participants with red or blond hair, those with CMM were twice as likely to carry GSTM1 null (OR, 2.2; 95% CI, 1.2-4.2) and nearly 10-fold more likely to carry both GSTM1 null and GSTT1 null (OR, 9.5; 95% CI, 1.2-73) compared with those without CMM. These data suggest that among persons with hair colors traditionally associated with increased risk for melanoma, absence of both GSTM1 and GSTT1 may act to further elevate CMM risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352862

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?

Authors:  Peter A Kanetsky; Saarene Panossian; David E Elder; DuPont Guerry; Michael E Ming; Lynn Schuchter; Timothy R Rebbeck
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

2.  Practical and analytical aspects of using friend controls in case-control studies: experience from a case-control study of childhood cancer.

Authors:  Greta R Bunin; Saran Vardhanabhuti; Agueda Lin; Greta L Anschuetz; Nandita Mitra
Journal:  Paediatr Perinat Epidemiol       Date:  2011-07-19       Impact factor: 3.980

3.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

4.  Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer.

Authors:  Zeyuan Lei; Ting Liu; Xiang Li; Xiaoxia Xu; Dongli Fan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressors.

Authors:  J Stebbing; M Bower; B Gazzard; A Wildfire; H Pandha; A Dalgleish; J Spicer
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

6.  Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Ruth M Pfeiffer; William Wheeler; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

7.  Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  Amanda B Spurdle; Paul Fahey; Xiaoqing Chen; Lesley McGuffog; Douglas Easton; Susan Peock; Margaret Cook; Jacques Simard; Tim R Rebbeck; Antonis C Antoniou; Georgia Chenevix-Trench
Journal:  Breast Cancer Res Treat       Date:  2009-11-18       Impact factor: 4.872

8.  A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.

Authors:  Yu-mei Chang; Julia A Newton-Bishop; D Timothy Bishop; Bruce K Armstrong; Veronique Bataille; Wilma Bergman; Marianne Berwick; Paige M Bracci; J Mark Elwood; Marc S Ernstoff; Adèle C Green; Nelleke A Gruis; Elizabeth A Holly; Christian Ingvar; Peter A Kanetsky; Margaret R Karagas; Loïc Le Marchand; Rona M Mackie; Håkan Olsson; Anne Østerlind; Timothy R Rebbeck; Kristian Reich; Peter Sasieni; Victor Siskind; Anthony J Swerdlow; Linda Titus-Ernstoff; Michael S Zens; Andreas Ziegler; Jennifer H Barrett
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

9.  Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.

Authors:  Valérie Chaudru; M T Lo; F Lesueur; C Marian; H Mohamdi; K Laud; M Barrois; A Chompret; M F Avril; F Demenais; B Bressac-de Paillerets
Journal:  Fam Cancer       Date:  2009-05-31       Impact factor: 2.375

10.  Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis.

Authors:  Hao Peng; Quanyong He; Jie Zhu; Cheng Peng
Journal:  Tumour Biol       Date:  2012-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.